- Home
- BLCO vs HESM Comparison
BLCO vs HESM Comparison
Compare BLCO & HESM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- HESM
- Stock Information
- Founded
- BLCO 1853
- HESM 2014
- Country
- BLCO Canada
- HESM United States
- Employees
- BLCO N/A
- HESM 220
- Industry
- BLCO Ophthalmic Goods
- HESM Oil & Gas Production
- Sector
- BLCO Health Care
- HESM Energy
- Exchange
- BLCO Nasdaq
- HESM Nasdaq
- Market Cap
- BLCO 4.0B
- HESM 4.3B
- IPO Year
- BLCO 2022
- HESM N/A
- Fundamental
- Price
- BLCO $11.87
- HESM $37.37
- Analyst Decision
- BLCO Hold
- HESM Buy
- Analyst Count
- BLCO 12
- HESM 5
- Target Price
- BLCO $18.64
- HESM $43.60
- AVG Volume (30 Days)
- BLCO 906.7K
- HESM 1.4M
- Earning Date
- BLCO 04-30-2025
- HESM 04-28-2025
- Dividend Yield
- BLCO N/A
- HESM 7.36%
- EPS Growth
- BLCO N/A
- HESM 19.71
- EPS
- BLCO N/A
- HESM 2.49
- Revenue
- BLCO $4,791,000,000.00
- HESM $1,495,500,000.00
- Revenue This Year
- BLCO $6.43
- HESM $13.34
- Revenue Next Year
- BLCO $5.59
- HESM $11.09
- P/E Ratio
- BLCO N/A
- HESM $14.76
- Revenue Growth
- BLCO 15.56
- HESM 10.89
- 52 Week Low
- BLCO $10.46
- HESM $32.75
- 52 Week High
- BLCO $21.69
- HESM $44.05
- Technical
- Relative Strength Index (RSI)
- BLCO 36.46
- HESM 41.48
- Support Level
- BLCO $10.46
- HESM $34.26
- Resistance Level
- BLCO $12.38
- HESM $37.70
- Average True Range (ATR)
- BLCO 0.92
- HESM 1.65
- MACD
- BLCO -0.09
- HESM -0.26
- Stochastic Oscillator
- BLCO 33.02
- HESM 40.26
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About HESM Hess Midstream LP Share
Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.